Global Hyperimmune Globulin Injection Market Research Report 2024(Status and Outlook)
Report Overview:
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The Global Hyperimmune Globulin Injection Market Size was estimated at USD 1983.59 million in 2023 and is projected to reach USD 2845.76 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Hyperimmune Globulin Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hyperimmune Globulin Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hyperimmune Globulin Injection market in any manner.
Global Hyperimmune Globulin Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market Segmentation (by Type)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market Segmentation (by Application)
Government Institution
Private Sector
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hyperimmune Globulin Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The Global Hyperimmune Globulin Injection Market Size was estimated at USD 1983.59 million in 2023 and is projected to reach USD 2845.76 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Hyperimmune Globulin Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hyperimmune Globulin Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hyperimmune Globulin Injection market in any manner.
Global Hyperimmune Globulin Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market Segmentation (by Type)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market Segmentation (by Application)
Government Institution
Private Sector
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hyperimmune Globulin Injection Market
- Overview of the regional outlook of the Hyperimmune Globulin Injection Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hyperimmune Globulin Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hyperimmune Globulin Injection
1.2 Key Market Segments
1.2.1 Hyperimmune Globulin Injection Segment by Type
1.2.2 Hyperimmune Globulin Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HYPERIMMUNE GLOBULIN INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hyperimmune Globulin Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hyperimmune Globulin Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HYPERIMMUNE GLOBULIN INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Hyperimmune Globulin Injection Sales by Manufacturers (2019-2024)
3.2 Global Hyperimmune Globulin Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Hyperimmune Globulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hyperimmune Globulin Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hyperimmune Globulin Injection Sales Sites, Area Served, Product Type
3.6 Hyperimmune Globulin Injection Market Competitive Situation and Trends
3.6.1 Hyperimmune Globulin Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hyperimmune Globulin Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HYPERIMMUNE GLOBULIN INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Hyperimmune Globulin Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HYPERIMMUNE GLOBULIN INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HYPERIMMUNE GLOBULIN INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hyperimmune Globulin Injection Sales Market Share by Type (2019-2024)
6.3 Global Hyperimmune Globulin Injection Market Size Market Share by Type (2019-2024)
6.4 Global Hyperimmune Globulin Injection Price by Type (2019-2024)
7 HYPERIMMUNE GLOBULIN INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hyperimmune Globulin Injection Market Sales by Application (2019-2024)
7.3 Global Hyperimmune Globulin Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Hyperimmune Globulin Injection Sales Growth Rate by Application (2019-2024)
8 HYPERIMMUNE GLOBULIN INJECTION MARKET SEGMENTATION BY REGION
8.1 Global Hyperimmune Globulin Injection Sales by Region
8.1.1 Global Hyperimmune Globulin Injection Sales by Region
8.1.2 Global Hyperimmune Globulin Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Hyperimmune Globulin Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hyperimmune Globulin Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hyperimmune Globulin Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hyperimmune Globulin Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hyperimmune Globulin Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring
9.1.1 CSL Behring Hyperimmune Globulin Injection Basic Information
9.1.2 CSL Behring Hyperimmune Globulin Injection Product Overview
9.1.3 CSL Behring Hyperimmune Globulin Injection Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Hyperimmune Globulin Injection SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Hyperimmune Globulin Injection Basic Information
9.2.2 Grifols Hyperimmune Globulin Injection Product Overview
9.2.3 Grifols Hyperimmune Globulin Injection Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Hyperimmune Globulin Injection SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Biotest
9.3.1 Biotest Hyperimmune Globulin Injection Basic Information
9.3.2 Biotest Hyperimmune Globulin Injection Product Overview
9.3.3 Biotest Hyperimmune Globulin Injection Product Market Performance
9.3.4 Biotest Hyperimmune Globulin Injection SWOT Analysis
9.3.5 Biotest Business Overview
9.3.6 Biotest Recent Developments
9.4 Kedrion
9.4.1 Kedrion Hyperimmune Globulin Injection Basic Information
9.4.2 Kedrion Hyperimmune Globulin Injection Product Overview
9.4.3 Kedrion Hyperimmune Globulin Injection Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Recent Developments
9.5 CBPO
9.5.1 CBPO Hyperimmune Globulin Injection Basic Information
9.5.2 CBPO Hyperimmune Globulin Injection Product Overview
9.5.3 CBPO Hyperimmune Globulin Injection Product Market Performance
9.5.4 CBPO Business Overview
9.5.5 CBPO Recent Developments
9.6 Emergent (Cangene)
9.6.1 Emergent (Cangene) Hyperimmune Globulin Injection Basic Information
9.6.2 Emergent (Cangene) Hyperimmune Globulin Injection Product Overview
9.6.3 Emergent (Cangene) Hyperimmune Globulin Injection Product Market Performance
9.6.4 Emergent (Cangene) Business Overview
9.6.5 Emergent (Cangene) Recent Developments
9.7 Kamada
9.7.1 Kamada Hyperimmune Globulin Injection Basic Information
9.7.2 Kamada Hyperimmune Globulin Injection Product Overview
9.7.3 Kamada Hyperimmune Globulin Injection Product Market Performance
9.7.4 Kamada Business Overview
9.7.5 Kamada Recent Developments
9.8 CNBG
9.8.1 CNBG Hyperimmune Globulin Injection Basic Information
9.8.2 CNBG Hyperimmune Globulin Injection Product Overview
9.8.3 CNBG Hyperimmune Globulin Injection Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Hualan Bio
9.9.1 Hualan Bio Hyperimmune Globulin Injection Basic Information
9.9.2 Hualan Bio Hyperimmune Globulin Injection Product Overview
9.9.3 Hualan Bio Hyperimmune Globulin Injection Product Market Performance
9.9.4 Hualan Bio Business Overview
9.9.5 Hualan Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Hyperimmune Globulin Injection Basic Information
9.10.2 Shanghai RAAS Hyperimmune Globulin Injection Product Overview
9.10.3 Shanghai RAAS Hyperimmune Globulin Injection Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Sichuan Yuanda Shuyang
9.11.1 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Basic Information
9.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Overview
9.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Market Performance
9.11.4 Sichuan Yuanda Shuyang Business Overview
9.11.5 Sichuan Yuanda Shuyang Recent Developments
9.12 ADMA Biologics
9.12.1 ADMA Biologics Hyperimmune Globulin Injection Basic Information
9.12.2 ADMA Biologics Hyperimmune Globulin Injection Product Overview
9.12.3 ADMA Biologics Hyperimmune Globulin Injection Product Market Performance
9.12.4 ADMA Biologics Business Overview
9.12.5 ADMA Biologics Recent Developments
10 HYPERIMMUNE GLOBULIN INJECTION MARKET FORECAST BY REGION
10.1 Global Hyperimmune Globulin Injection Market Size Forecast
10.2 Global Hyperimmune Globulin Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hyperimmune Globulin Injection Market Size Forecast by Country
10.2.3 Asia Pacific Hyperimmune Globulin Injection Market Size Forecast by Region
10.2.4 South America Hyperimmune Globulin Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hyperimmune Globulin Injection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hyperimmune Globulin Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hyperimmune Globulin Injection by Type (2025-2030)
11.1.2 Global Hyperimmune Globulin Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hyperimmune Globulin Injection by Type (2025-2030)
11.2 Global Hyperimmune Globulin Injection Market Forecast by Application (2025-2030)
11.2.1 Global Hyperimmune Globulin Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Hyperimmune Globulin Injection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hyperimmune Globulin Injection
1.2 Key Market Segments
1.2.1 Hyperimmune Globulin Injection Segment by Type
1.2.2 Hyperimmune Globulin Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HYPERIMMUNE GLOBULIN INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hyperimmune Globulin Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hyperimmune Globulin Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HYPERIMMUNE GLOBULIN INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Hyperimmune Globulin Injection Sales by Manufacturers (2019-2024)
3.2 Global Hyperimmune Globulin Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Hyperimmune Globulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hyperimmune Globulin Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hyperimmune Globulin Injection Sales Sites, Area Served, Product Type
3.6 Hyperimmune Globulin Injection Market Competitive Situation and Trends
3.6.1 Hyperimmune Globulin Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hyperimmune Globulin Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HYPERIMMUNE GLOBULIN INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Hyperimmune Globulin Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HYPERIMMUNE GLOBULIN INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HYPERIMMUNE GLOBULIN INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hyperimmune Globulin Injection Sales Market Share by Type (2019-2024)
6.3 Global Hyperimmune Globulin Injection Market Size Market Share by Type (2019-2024)
6.4 Global Hyperimmune Globulin Injection Price by Type (2019-2024)
7 HYPERIMMUNE GLOBULIN INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hyperimmune Globulin Injection Market Sales by Application (2019-2024)
7.3 Global Hyperimmune Globulin Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Hyperimmune Globulin Injection Sales Growth Rate by Application (2019-2024)
8 HYPERIMMUNE GLOBULIN INJECTION MARKET SEGMENTATION BY REGION
8.1 Global Hyperimmune Globulin Injection Sales by Region
8.1.1 Global Hyperimmune Globulin Injection Sales by Region
8.1.2 Global Hyperimmune Globulin Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Hyperimmune Globulin Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hyperimmune Globulin Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hyperimmune Globulin Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hyperimmune Globulin Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hyperimmune Globulin Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring
9.1.1 CSL Behring Hyperimmune Globulin Injection Basic Information
9.1.2 CSL Behring Hyperimmune Globulin Injection Product Overview
9.1.3 CSL Behring Hyperimmune Globulin Injection Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Hyperimmune Globulin Injection SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Hyperimmune Globulin Injection Basic Information
9.2.2 Grifols Hyperimmune Globulin Injection Product Overview
9.2.3 Grifols Hyperimmune Globulin Injection Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Hyperimmune Globulin Injection SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Biotest
9.3.1 Biotest Hyperimmune Globulin Injection Basic Information
9.3.2 Biotest Hyperimmune Globulin Injection Product Overview
9.3.3 Biotest Hyperimmune Globulin Injection Product Market Performance
9.3.4 Biotest Hyperimmune Globulin Injection SWOT Analysis
9.3.5 Biotest Business Overview
9.3.6 Biotest Recent Developments
9.4 Kedrion
9.4.1 Kedrion Hyperimmune Globulin Injection Basic Information
9.4.2 Kedrion Hyperimmune Globulin Injection Product Overview
9.4.3 Kedrion Hyperimmune Globulin Injection Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Recent Developments
9.5 CBPO
9.5.1 CBPO Hyperimmune Globulin Injection Basic Information
9.5.2 CBPO Hyperimmune Globulin Injection Product Overview
9.5.3 CBPO Hyperimmune Globulin Injection Product Market Performance
9.5.4 CBPO Business Overview
9.5.5 CBPO Recent Developments
9.6 Emergent (Cangene)
9.6.1 Emergent (Cangene) Hyperimmune Globulin Injection Basic Information
9.6.2 Emergent (Cangene) Hyperimmune Globulin Injection Product Overview
9.6.3 Emergent (Cangene) Hyperimmune Globulin Injection Product Market Performance
9.6.4 Emergent (Cangene) Business Overview
9.6.5 Emergent (Cangene) Recent Developments
9.7 Kamada
9.7.1 Kamada Hyperimmune Globulin Injection Basic Information
9.7.2 Kamada Hyperimmune Globulin Injection Product Overview
9.7.3 Kamada Hyperimmune Globulin Injection Product Market Performance
9.7.4 Kamada Business Overview
9.7.5 Kamada Recent Developments
9.8 CNBG
9.8.1 CNBG Hyperimmune Globulin Injection Basic Information
9.8.2 CNBG Hyperimmune Globulin Injection Product Overview
9.8.3 CNBG Hyperimmune Globulin Injection Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Hualan Bio
9.9.1 Hualan Bio Hyperimmune Globulin Injection Basic Information
9.9.2 Hualan Bio Hyperimmune Globulin Injection Product Overview
9.9.3 Hualan Bio Hyperimmune Globulin Injection Product Market Performance
9.9.4 Hualan Bio Business Overview
9.9.5 Hualan Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Hyperimmune Globulin Injection Basic Information
9.10.2 Shanghai RAAS Hyperimmune Globulin Injection Product Overview
9.10.3 Shanghai RAAS Hyperimmune Globulin Injection Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Sichuan Yuanda Shuyang
9.11.1 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Basic Information
9.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Overview
9.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Market Performance
9.11.4 Sichuan Yuanda Shuyang Business Overview
9.11.5 Sichuan Yuanda Shuyang Recent Developments
9.12 ADMA Biologics
9.12.1 ADMA Biologics Hyperimmune Globulin Injection Basic Information
9.12.2 ADMA Biologics Hyperimmune Globulin Injection Product Overview
9.12.3 ADMA Biologics Hyperimmune Globulin Injection Product Market Performance
9.12.4 ADMA Biologics Business Overview
9.12.5 ADMA Biologics Recent Developments
10 HYPERIMMUNE GLOBULIN INJECTION MARKET FORECAST BY REGION
10.1 Global Hyperimmune Globulin Injection Market Size Forecast
10.2 Global Hyperimmune Globulin Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hyperimmune Globulin Injection Market Size Forecast by Country
10.2.3 Asia Pacific Hyperimmune Globulin Injection Market Size Forecast by Region
10.2.4 South America Hyperimmune Globulin Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hyperimmune Globulin Injection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hyperimmune Globulin Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hyperimmune Globulin Injection by Type (2025-2030)
11.1.2 Global Hyperimmune Globulin Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hyperimmune Globulin Injection by Type (2025-2030)
11.2 Global Hyperimmune Globulin Injection Market Forecast by Application (2025-2030)
11.2.1 Global Hyperimmune Globulin Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Hyperimmune Globulin Injection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hyperimmune Globulin Injection Market Size Comparison by Region (M USD)
Table 5. Global Hyperimmune Globulin Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hyperimmune Globulin Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hyperimmune Globulin Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hyperimmune Globulin Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulin Injection as of 2022)
Table 10. Global Market Hyperimmune Globulin Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hyperimmune Globulin Injection Sales Sites and Area Served
Table 12. Manufacturers Hyperimmune Globulin Injection Product Type
Table 13. Global Hyperimmune Globulin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hyperimmune Globulin Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hyperimmune Globulin Injection Market Challenges
Table 22. Global Hyperimmune Globulin Injection Sales by Type (Kilotons)
Table 23. Global Hyperimmune Globulin Injection Market Size by Type (M USD)
Table 24. Global Hyperimmune Globulin Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hyperimmune Globulin Injection Sales Market Share by Type (2019-2024)
Table 26. Global Hyperimmune Globulin Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Hyperimmune Globulin Injection Market Size Share by Type (2019-2024)
Table 28. Global Hyperimmune Globulin Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hyperimmune Globulin Injection Sales (Kilotons) by Application
Table 30. Global Hyperimmune Globulin Injection Market Size by Application
Table 31. Global Hyperimmune Globulin Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hyperimmune Globulin Injection Sales Market Share by Application (2019-2024)
Table 33. Global Hyperimmune Globulin Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Hyperimmune Globulin Injection Market Share by Application (2019-2024)
Table 35. Global Hyperimmune Globulin Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Hyperimmune Globulin Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hyperimmune Globulin Injection Sales Market Share by Region (2019-2024)
Table 38. North America Hyperimmune Globulin Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hyperimmune Globulin Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hyperimmune Globulin Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hyperimmune Globulin Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hyperimmune Globulin Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Behring Hyperimmune Globulin Injection Basic Information
Table 44. CSL Behring Hyperimmune Globulin Injection Product Overview
Table 45. CSL Behring Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Behring Business Overview
Table 47. CSL Behring Hyperimmune Globulin Injection SWOT Analysis
Table 48. CSL Behring Recent Developments
Table 49. Grifols Hyperimmune Globulin Injection Basic Information
Table 50. Grifols Hyperimmune Globulin Injection Product Overview
Table 51. Grifols Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Hyperimmune Globulin Injection SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Biotest Hyperimmune Globulin Injection Basic Information
Table 56. Biotest Hyperimmune Globulin Injection Product Overview
Table 57. Biotest Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biotest Hyperimmune Globulin Injection SWOT Analysis
Table 59. Biotest Business Overview
Table 60. Biotest Recent Developments
Table 61. Kedrion Hyperimmune Globulin Injection Basic Information
Table 62. Kedrion Hyperimmune Globulin Injection Product Overview
Table 63. Kedrion Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kedrion Business Overview
Table 65. Kedrion Recent Developments
Table 66. CBPO Hyperimmune Globulin Injection Basic Information
Table 67. CBPO Hyperimmune Globulin Injection Product Overview
Table 68. CBPO Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CBPO Business Overview
Table 70. CBPO Recent Developments
Table 71. Emergent (Cangene) Hyperimmune Globulin Injection Basic Information
Table 72. Emergent (Cangene) Hyperimmune Globulin Injection Product Overview
Table 73. Emergent (Cangene) Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Emergent (Cangene) Business Overview
Table 75. Emergent (Cangene) Recent Developments
Table 76. Kamada Hyperimmune Globulin Injection Basic Information
Table 77. Kamada Hyperimmune Globulin Injection Product Overview
Table 78. Kamada Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Kamada Business Overview
Table 80. Kamada Recent Developments
Table 81. CNBG Hyperimmune Globulin Injection Basic Information
Table 82. CNBG Hyperimmune Globulin Injection Product Overview
Table 83. CNBG Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CNBG Business Overview
Table 85. CNBG Recent Developments
Table 86. Hualan Bio Hyperimmune Globulin Injection Basic Information
Table 87. Hualan Bio Hyperimmune Globulin Injection Product Overview
Table 88. Hualan Bio Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hualan Bio Business Overview
Table 90. Hualan Bio Recent Developments
Table 91. Shanghai RAAS Hyperimmune Globulin Injection Basic Information
Table 92. Shanghai RAAS Hyperimmune Globulin Injection Product Overview
Table 93. Shanghai RAAS Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shanghai RAAS Business Overview
Table 95. Shanghai RAAS Recent Developments
Table 96. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Basic Information
Table 97. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Overview
Table 98. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sichuan Yuanda Shuyang Business Overview
Table 100. Sichuan Yuanda Shuyang Recent Developments
Table 101. ADMA Biologics Hyperimmune Globulin Injection Basic Information
Table 102. ADMA Biologics Hyperimmune Globulin Injection Product Overview
Table 103. ADMA Biologics Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. ADMA Biologics Business Overview
Table 105. ADMA Biologics Recent Developments
Table 106. Global Hyperimmune Globulin Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Hyperimmune Globulin Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Hyperimmune Globulin Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Hyperimmune Globulin Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Hyperimmune Globulin Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Hyperimmune Globulin Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Hyperimmune Globulin Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Hyperimmune Globulin Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Hyperimmune Globulin Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Hyperimmune Globulin Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Hyperimmune Globulin Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Hyperimmune Globulin Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Hyperimmune Globulin Injection Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hyperimmune Globulin Injection Market Size Comparison by Region (M USD)
Table 5. Global Hyperimmune Globulin Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hyperimmune Globulin Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hyperimmune Globulin Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hyperimmune Globulin Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulin Injection as of 2022)
Table 10. Global Market Hyperimmune Globulin Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hyperimmune Globulin Injection Sales Sites and Area Served
Table 12. Manufacturers Hyperimmune Globulin Injection Product Type
Table 13. Global Hyperimmune Globulin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hyperimmune Globulin Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hyperimmune Globulin Injection Market Challenges
Table 22. Global Hyperimmune Globulin Injection Sales by Type (Kilotons)
Table 23. Global Hyperimmune Globulin Injection Market Size by Type (M USD)
Table 24. Global Hyperimmune Globulin Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hyperimmune Globulin Injection Sales Market Share by Type (2019-2024)
Table 26. Global Hyperimmune Globulin Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Hyperimmune Globulin Injection Market Size Share by Type (2019-2024)
Table 28. Global Hyperimmune Globulin Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hyperimmune Globulin Injection Sales (Kilotons) by Application
Table 30. Global Hyperimmune Globulin Injection Market Size by Application
Table 31. Global Hyperimmune Globulin Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hyperimmune Globulin Injection Sales Market Share by Application (2019-2024)
Table 33. Global Hyperimmune Globulin Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Hyperimmune Globulin Injection Market Share by Application (2019-2024)
Table 35. Global Hyperimmune Globulin Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Hyperimmune Globulin Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hyperimmune Globulin Injection Sales Market Share by Region (2019-2024)
Table 38. North America Hyperimmune Globulin Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hyperimmune Globulin Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hyperimmune Globulin Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hyperimmune Globulin Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hyperimmune Globulin Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Behring Hyperimmune Globulin Injection Basic Information
Table 44. CSL Behring Hyperimmune Globulin Injection Product Overview
Table 45. CSL Behring Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Behring Business Overview
Table 47. CSL Behring Hyperimmune Globulin Injection SWOT Analysis
Table 48. CSL Behring Recent Developments
Table 49. Grifols Hyperimmune Globulin Injection Basic Information
Table 50. Grifols Hyperimmune Globulin Injection Product Overview
Table 51. Grifols Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Hyperimmune Globulin Injection SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Biotest Hyperimmune Globulin Injection Basic Information
Table 56. Biotest Hyperimmune Globulin Injection Product Overview
Table 57. Biotest Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biotest Hyperimmune Globulin Injection SWOT Analysis
Table 59. Biotest Business Overview
Table 60. Biotest Recent Developments
Table 61. Kedrion Hyperimmune Globulin Injection Basic Information
Table 62. Kedrion Hyperimmune Globulin Injection Product Overview
Table 63. Kedrion Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kedrion Business Overview
Table 65. Kedrion Recent Developments
Table 66. CBPO Hyperimmune Globulin Injection Basic Information
Table 67. CBPO Hyperimmune Globulin Injection Product Overview
Table 68. CBPO Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CBPO Business Overview
Table 70. CBPO Recent Developments
Table 71. Emergent (Cangene) Hyperimmune Globulin Injection Basic Information
Table 72. Emergent (Cangene) Hyperimmune Globulin Injection Product Overview
Table 73. Emergent (Cangene) Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Emergent (Cangene) Business Overview
Table 75. Emergent (Cangene) Recent Developments
Table 76. Kamada Hyperimmune Globulin Injection Basic Information
Table 77. Kamada Hyperimmune Globulin Injection Product Overview
Table 78. Kamada Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Kamada Business Overview
Table 80. Kamada Recent Developments
Table 81. CNBG Hyperimmune Globulin Injection Basic Information
Table 82. CNBG Hyperimmune Globulin Injection Product Overview
Table 83. CNBG Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CNBG Business Overview
Table 85. CNBG Recent Developments
Table 86. Hualan Bio Hyperimmune Globulin Injection Basic Information
Table 87. Hualan Bio Hyperimmune Globulin Injection Product Overview
Table 88. Hualan Bio Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hualan Bio Business Overview
Table 90. Hualan Bio Recent Developments
Table 91. Shanghai RAAS Hyperimmune Globulin Injection Basic Information
Table 92. Shanghai RAAS Hyperimmune Globulin Injection Product Overview
Table 93. Shanghai RAAS Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shanghai RAAS Business Overview
Table 95. Shanghai RAAS Recent Developments
Table 96. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Basic Information
Table 97. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Overview
Table 98. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sichuan Yuanda Shuyang Business Overview
Table 100. Sichuan Yuanda Shuyang Recent Developments
Table 101. ADMA Biologics Hyperimmune Globulin Injection Basic Information
Table 102. ADMA Biologics Hyperimmune Globulin Injection Product Overview
Table 103. ADMA Biologics Hyperimmune Globulin Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. ADMA Biologics Business Overview
Table 105. ADMA Biologics Recent Developments
Table 106. Global Hyperimmune Globulin Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Hyperimmune Globulin Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Hyperimmune Globulin Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Hyperimmune Globulin Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Hyperimmune Globulin Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Hyperimmune Globulin Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Hyperimmune Globulin Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Hyperimmune Globulin Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Hyperimmune Globulin Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Hyperimmune Globulin Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Hyperimmune Globulin Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Hyperimmune Globulin Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Hyperimmune Globulin Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Hyperimmune Globulin Injection Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hyperimmune Globulin Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hyperimmune Globulin Injection Market Size (M USD), 2019-2030
Figure 5. Global Hyperimmune Globulin Injection Market Size (M USD) (2019-2030)
Figure 6. Global Hyperimmune Globulin Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hyperimmune Globulin Injection Market Size by Country (M USD)
Figure 11. Hyperimmune Globulin Injection Sales Share by Manufacturers in 2023
Figure 12. Global Hyperimmune Globulin Injection Revenue Share by Manufacturers in 2023
Figure 13. Hyperimmune Globulin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hyperimmune Globulin Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hyperimmune Globulin Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hyperimmune Globulin Injection Market Share by Type
Figure 18. Sales Market Share of Hyperimmune Globulin Injection by Type (2019-2024)
Figure 19. Sales Market Share of Hyperimmune Globulin Injection by Type in 2023
Figure 20. Market Size Share of Hyperimmune Globulin Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Hyperimmune Globulin Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hyperimmune Globulin Injection Market Share by Application
Figure 24. Global Hyperimmune Globulin Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Hyperimmune Globulin Injection Sales Market Share by Application in 2023
Figure 26. Global Hyperimmune Globulin Injection Market Share by Application (2019-2024)
Figure 27. Global Hyperimmune Globulin Injection Market Share by Application in 2023
Figure 28. Global Hyperimmune Globulin Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hyperimmune Globulin Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hyperimmune Globulin Injection Sales Market Share by Country in 2023
Figure 32. U.S. Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hyperimmune Globulin Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hyperimmune Globulin Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hyperimmune Globulin Injection Sales Market Share by Country in 2023
Figure 37. Germany Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hyperimmune Globulin Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hyperimmune Globulin Injection Sales Market Share by Region in 2023
Figure 44. China Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hyperimmune Globulin Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Hyperimmune Globulin Injection Sales Market Share by Country in 2023
Figure 51. Brazil Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hyperimmune Globulin Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hyperimmune Globulin Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hyperimmune Globulin Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hyperimmune Globulin Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hyperimmune Globulin Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Hyperimmune Globulin Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Hyperimmune Globulin Injection Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hyperimmune Globulin Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hyperimmune Globulin Injection Market Size (M USD), 2019-2030
Figure 5. Global Hyperimmune Globulin Injection Market Size (M USD) (2019-2030)
Figure 6. Global Hyperimmune Globulin Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hyperimmune Globulin Injection Market Size by Country (M USD)
Figure 11. Hyperimmune Globulin Injection Sales Share by Manufacturers in 2023
Figure 12. Global Hyperimmune Globulin Injection Revenue Share by Manufacturers in 2023
Figure 13. Hyperimmune Globulin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hyperimmune Globulin Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hyperimmune Globulin Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hyperimmune Globulin Injection Market Share by Type
Figure 18. Sales Market Share of Hyperimmune Globulin Injection by Type (2019-2024)
Figure 19. Sales Market Share of Hyperimmune Globulin Injection by Type in 2023
Figure 20. Market Size Share of Hyperimmune Globulin Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Hyperimmune Globulin Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hyperimmune Globulin Injection Market Share by Application
Figure 24. Global Hyperimmune Globulin Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Hyperimmune Globulin Injection Sales Market Share by Application in 2023
Figure 26. Global Hyperimmune Globulin Injection Market Share by Application (2019-2024)
Figure 27. Global Hyperimmune Globulin Injection Market Share by Application in 2023
Figure 28. Global Hyperimmune Globulin Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hyperimmune Globulin Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hyperimmune Globulin Injection Sales Market Share by Country in 2023
Figure 32. U.S. Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hyperimmune Globulin Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hyperimmune Globulin Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hyperimmune Globulin Injection Sales Market Share by Country in 2023
Figure 37. Germany Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hyperimmune Globulin Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hyperimmune Globulin Injection Sales Market Share by Region in 2023
Figure 44. China Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hyperimmune Globulin Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Hyperimmune Globulin Injection Sales Market Share by Country in 2023
Figure 51. Brazil Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hyperimmune Globulin Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hyperimmune Globulin Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hyperimmune Globulin Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hyperimmune Globulin Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hyperimmune Globulin Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hyperimmune Globulin Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Hyperimmune Globulin Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Hyperimmune Globulin Injection Market Share Forecast by Application (2025-2030)
